Hyaluronic acid (HA) is a glycosaminoglycan that holds 1,000x its weight in water — the primary molecule responsible for skin hydration, joint lubrication, and tissue cushioning. While injected HA is the gold standard for knee osteoarthritis and dermal fillers, our research shows ORAL HA (80-200mg/day) genuinely improves skin moisture (27% increase at 12 weeks) and modestly reduces knee pain. The critical finding: molecular weight matters enormously — low molecular weight (LMW) HA (<50 kDa) is absorbed orally but may be PRO-inflammatory, while high molecular weight (HMW) HA is anti-inflammatory but poorly absorbed. Medium molecular weight (300-800 kDa) appears to be the sweet spot.
Oral HA is partially degraded by gut bacteria and gastric acid into smaller fragments, which are absorbed in the small intestine. These fragments distribute to skin and joint tissues where they: (1) directly contribute to extracellular matrix hydration (HA holds 1,000x its weight in water); (2) stimulate fibroblasts to produce MORE endogenous HA (amplification effect); (3) signal via CD44 receptors to increase collagen and elastin production. In joints, HA provides viscous lubrication (viscosupplementation) and cushioning. The key insight: oral HA appears to STIMULATE local HA production rather than simply replacing it — which is why relatively small oral doses produce measurable effects.
No critical interactions identified for oral supplementation.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.